No Data
No Data
Express News | Zhende medical: Continuing to seek external development opportunities around the core business of "medical + health."
Zhende Medical: The US tariff policy has no impact on the company yet, and the Mexican production base may be completed next year | Direct hit on earnings conference
①Zhende Medical's chairman Lu Jianguo introduced at the earnings conference that the construction of the new production base in Mexico is expected to be completed next year; ② Zhende Medical explained the company's Q3 operation situation, with further decrease in revenue from isolation protective equipment.
Zhende Medical (603301): Revenue meets expectations, with a sharp increase in non-net income after excluding exchange rate effects.
Item: The company released the third quarter report of 24 years, 24Q1-3, with revenue of 3.125 billion yuan (-2.61%), net income attributable to the parent company of 0.307 billion yuan (+2.31%), and non-GAAP net income of 0.225 billion yuan (-20%).
Zhende Medical (603301): Income in the third quarter of 2024 increased by 20%. Inventory clearance affected by overseas business.
In Q3 2024, both revenue and net income attributable to the parent achieved an increase compared to the same period and the previous quarter, with asset disposal gains contributing significantly to the apparent profit growth. The company achieved revenue of 3.125 billion yuan (-2.61%) and a net income of 3.07 billion yuan in the first three quarters of 2024.
Zhende Medical Report for the Third Quarter of 2024
Express News | Zhende Medical: One of the controlling shareholders and concerted actors terminates the shareholding reduction plan ahead of schedule.
No Data